Noubar Afeyan

This profile gathers the share dealings of Noubar Afeyan across 2 companies, led by Moderna, Inc. and Generate Biomedicines, Inc. We count 91 filings; the first trade dates from 28 April 2022 and the latest from 21 May 2026.

On the market, this insider has only sold: 86 sales, €104.8M in total. Outside the open market, there are 3 option exercises. 2026 to date brings no purchases and 1 sale.

On 22 May 2026 came the latest disclosure, an option exercise for €153k in Moderna, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.